Results 281 to 290 of about 96,571 (302)
Some of the next articles are maybe not open access.

18-Fluorodeoxyglucose imaging in oncology.

The Journal of the Oklahoma State Medical Association, 1999
This article describes the use of 18-fluorodeoxyglucose (FDG) scans for the diagnostic evaluation of cancer patients. Since FDG is a positron emitting radio-pharmaceutical, a dedicated Positron Emission Tomography unit (PET) or a hybrid PET/SPECT (single photon emission computed tomography) unit is required for oncologic studies.
openaire   +1 more source

Fluorodeoxyglucose Uptake in Atheroma

Journal of the American College of Cardiology, 2019
Peter Libby   +2 more
openaire   +1 more source

18F-fluorodeoxyglucose PET/Computed Tomography

PET Clinics, 2022
Stephen M. Broski   +3 more
openaire   +1 more source

Diagnostic performance of unenhanced computed tomography and 18F‐fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours

Clinical Endocrinology, 2018
D. Delivanis   +9 more
semanticscholar   +1 more source

Long‐term outcome of 18F‐fluorodeoxyglucose‐positron emission tomography‐guided dose painting for head and neck cancer: Matched case‐control study

Head and Neck, 2017
D. Berwouts   +10 more
semanticscholar   +1 more source

[18F]Fluorodeoxyglucose PET/CT Predicts Response to Steroid Therapy in Constrictive Pericarditis.

Journal of the American College of Cardiology, 2017
Sung‐A Chang   +9 more
semanticscholar   +1 more source

Fluorodeoxyglucose Positron Emission Tomography

2016
Flora M. Hammond, Sheryl Katta-Charles
openaire   +1 more source

Home - About - Disclaimer - Privacy